Guidance on transitional arrangements for applying for clinical trial approval.
Similar Posts
MHRA Safety Roundup: December 2025
Summary of the latest safety advice for medicines and medical device users
Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
Field Safety Notices: 15 – 19 December 2025
List of Field Safety Notices (FSNs) for week 15 – 19 December 2025
Clinical trials for medicines: expert advice
Clinical trial applications that need expert advice from a specialist group or committee.
Decision: Parallel import licences granted in 2025
Parallel import licences granted in 2025.
Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07
Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.